Cambi has entered into a contract with Watercare Services Limited to supply two
thermal hydrolysis process (THP) systems for the Rosedale wastewater treatment
plant in Auckland, New Zealand.

The contract begins with an engineering phase. Manufacturing is expected to
commence following a later notice to proceed and no earlier than 12 months from
now.

Thermal hydrolysis will increase digestion capacity at Rosedale without the need
for new digesters, support higher biogas production, improve dewatering, reduce
biosolids volumes for disposal, and reduce carbon footprint and waste while
lowering asset life-cycle costs.

Per Lillebø, CEO of Cambi, remarked:

"Rosedale is a strategically important project in a growing market and marks an
important contract for Cambi. Watercare, New Zealand's largest water utility, is
investing in long-term treatment capacity, improved performance, and reduced
emissions at a major wastewater treatment plant in Auckland. Cambi appreciates
the opportunity to support that programme with thermal hydrolysis technology
tailored to the site's requirements."

Watercare provides water and wastewater services to 1.7 million people in
Auckland and is upgrading the Rosedale plant as part of a broader investment
programme to support growth, improve treatment performance, and reduce
emissions. Rosedale is Watercare's second-largest wastewater treatment plant,
and the wider upgrade programme will increase wastewater flows reaching the
site.

The value of the engineering phase is equivalent to a small contract for Cambi,
while the total project value is equivalent to a large contract.

The project's current timeline has equipment delivery scheduled for 2028, with
operations starting in 2030.


For more information, please contact: 
- Per Lillebø, CEO, per.lilleboe@cambi.com, +47 918 88 365
- Per Olav Collin, Acting CFO, per.olav.collin@cambi.com, +47 986 48 572


Note on total contract value:
Category 	Large
NOK million	100-200


About Cambi

Cambi is a global supplier of biogas technology and solutions for wastewater
treatment plants and anaerobic digestion facilities. Since 1992, Cambi has
maintained market leadership through continuous innovation and a robust
portfolio of proven and patented technologies. With strong project delivery and
customer support capabilities, the company has delivered more than 100
well-performing installations in 28 countries on six continents.

Cambi's thermal hydrolysis process increases renewable energy output, improves
dewatering, reduces operating costs, and minimises greenhouse gas emissions. The
technology is suitable for both new and existing anaerobic digestion sites and
compatible with all biosolids outlets, including land application and downstream
thermal processes such as drying, pyrolysis and incineration. Thermal hydrolysis
is robust to regulatory changes and supports compliance with legal requirements
for biosolids and waste treatment.

Cambi is listed on Euronext Growth Oslo, a multilateral trading facility in
Euronext, Europe's largest stock exchange platform. Find out more at cambi.com.